title: PACE: Pharmacists use the power of communication in paediatric asthma.
abstract: BACKGROUND
  Paediatric asthma is a public health burden in Australia despite the availability of national asthma guidelines. Community pharmacy interventions focusing on paediatric asthma are scarce. Practitioner Asthma Communication and Education (PACE) is an evidence-based program, developed in the USA for general practice physicians, aimed at addressing the issues of poor clinician-patient communication in the management of paediatric asthma. This program has been shown to improve paediatric asthma management practices of general practitioners in the USA and Australia. The development of a PACE program for community pharmacists will fill a void in the current armamentarium for pharmacist-patient care.
  
  
  OBJECTIVE
  To adapt the educational program, PACE, to the community pharmacy setting. To test the feasibility of the new program for pharmacy and to explore its potential impact on pharmacists' communication skills and asthma related practices.
  
  
  METHODS
  Community pharmacies located within the Sydney metropolitan.
  
  
  METHODS
  The PACE framework was reviewed by the research team and amended in order to ensure its relevance within the pharmacy context, thereby developing PACE for Pharmacy. Forty-four pharmacists were recruited and trained in small groups in the PACE for Pharmacy workshops. Pharmacists' satisfaction and acceptability of the workshops, confidence in using communication strategies pre- and post-workshop and self-reported behaviour change post workshop were evaluated.
  
  
  METHODS
  Pharmacist self-reported changes in communication and teaching behaviours during a paediatric asthma consultation.
  
  
  RESULTS
  All 44 pharmacists attended both workshops, completed pre- and post-workshop questionnaires and provided feedback on the workshops (100 % retention). The participants reported a high level of satisfaction and valued the interactive nature of the workshops. Following the PACE for Pharmacy program, pharmacists reported significantly higher levels in using the communication strategies, confidence in their application and their helpfulness. Pharmacists checked for written asthma self-management plan possession and inhaler device technique more regularly, and provided verbal instructions more frequently to paediatric asthma patients/carers at the initiation of a new medication.
  
  
  CONCLUSIONS
  This study provides preliminary evidence that the PACE program can be translated into community pharmacy. PACE for Pharmacy positively affected self-reported communication and education behaviours of pharmacists. The high response rate shows that pharmacists are eager to expand on their clinical role in primary healthcare.
authors.affiliation: The Woolcock Institute of Medical Research, University of Sydney, Glebe, NSW, 2051, Australia, aela5708@uni.sydney.edu.au.
authors.forename: Amanda
authors.initials: A
authors.lastname: Elaro
authors.forename: Smita
authors.initials: S
authors.lastname: Shah
authors.forename: Luca N
authors.initials: LN
authors.lastname: Pomare
authors.forename: Carol
authors.initials: C
authors.lastname: L Armour
authors.forename: Sinthia
authors.initials: S
authors.lastname: Z Bosnic-Anticevich
mesh_terms: D000328:Adult; D001249:Asthma / Q000628:therapy*; D001291:Attitude of Health Personnel; D003142:Communication; D003157:Community Pharmacy Services; D004493:Education; D004513:Education, Pharmacy, Continuing; D005260:Female; D058005:General Practitioners; D006801:Humans; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D010353:Patient Education as Topic / Q000379:methods*; D010595:Pharmacists / Q000523:psychology; D024382:Professional Role; D055815:Young Adult
references.citation: Soc Sci Med. 2007 Apr;64(7):1501-11
references.pmid: 17202024
references.citation: Eur Respir J. 2008 Apr;31(4):790-9
references.pmid: 18094011
references.citation: Curr Opin Pediatr. 2008 Dec;20(6):705-10
references.pmid: 19005340
references.citation: J Paediatr Child Health. 2002 Jun;38(3):284-9
references.pmid: 12047698
references.citation: J Asthma. 2009 Jun;46(5):437-44
references.pmid: 19544161
references.citation: J Am Pharm Assoc (2003). 2007 Jul-Aug;47(4):521-6
references.pmid: 17616501
references.citation: J Allergy Clin Immunol. 2007 Jun;119(6):1537-8
references.pmid: 17433831
references.citation: Respir Med. 2011 Dec;105(12):1815-22
references.pmid: 21802271
references.citation: J Paediatr Child Health. 2007 May;43(5):342-52
references.pmid: 17489823
references.citation: Am J Pharm Educ. 2009 Apr 7;73(2):32
references.pmid: 19513170
references.citation: Pharm World Sci. 2007 Jun;29(3):228-39
references.pmid: 17242854
references.citation: Pediatrics. 1998 May;101(5):831-6
references.pmid: 9565410
references.citation: BMC Med Educ. 2014 Apr 07;14:72
references.pmid: 24708800
references.citation: Am J Health Syst Pharm. 2012 Mar 15;69(6):504-9
references.pmid: 22382482
references.citation: Ann Pharmacother. 2004 Nov;38(11):1954-60
references.pmid: 15479780
references.citation: Patient Educ Couns. 2011 Jun;83(3):295-302
references.pmid: 21621947
references.citation: J Allergy Clin Immunol. 2011 Jan;127(1):102-15
references.pmid: 21211645
references.citation: Pediatrics. 2006 Jun;117(6):2149-57
references.pmid: 16740859
references.citation: Respir Care. 2006 Jan;51(1):49-55
references.pmid: 16381618
references.citation: Thorax. 2007 Jun;62(6):496-502
references.pmid: 17251316
references.citation: Paediatr Respir Rev. 2003 Dec;4(4):325-33
references.pmid: 14629956
references.citation: Med J Aust. 2011 Oct 3;195(7):405-9
references.pmid: 21978349
references.citation: Cochrane Database Syst Rev. 2003;(1):CD001117
references.pmid: 12535399
references.citation: J Asthma. 2011 Dec;48(10):1085-103
references.pmid: 22013989
references.citation: Thorax. 2003 Oct;58(10):851-4
references.pmid: 14514935
references.citation: J Asthma. 2010 Apr;47(3):251-6
references.pmid: 20394511
references.citation: Aust J Prim Health. 2010;16(1):75-80
references.pmid: 21133302